Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.
Saved in:
| Title: | Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination. |
|---|---|
| Authors: | Gonzalez-Perez M; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Montes-Casado M; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Conde P; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Cervera I; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Baranda J; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Berges-Buxeda MJ; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Perez-Olmeda M; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Sanchez-Tarjuelo R; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Utrero-Rico A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Lozano-Ojalvo D; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Torre D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Schwarz M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Guccione E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Camara C; Department of Immunology, Hospital La Paz, Madrid, Spain., Llópez-Carratalá MR; Department of Nephrology, Hospital Puerta de Hierro, Madrid, Spain., Gonzalez-Parra E; Department of Nephrology, Instituto de Investigación Sanitaria (IIS)-Fundación Jimenez Díaz, Madrid, Spain., Portoles P; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Presidencia, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., Ortiz A; Department of Nephrology, Instituto de Investigación Sanitaria (IIS)-Fundación Jimenez Díaz, Madrid, Spain., Portoles J; Department of Nephrology, Hospital Puerta de Hierro, Madrid, Spain., Ochando J; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Mar 23; Vol. 13, pp. 845882. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2022.845882 |
